1021685-17-5

Basic information

• Product Name: 2-(benzyloxy)-7-methoxy-3-methyl-9H-carbazole
• Synonyms: 2-(benzyloxy)-7-methoxy-3-methyl-9H-carbazole
• CAS NO: 1021685-17-5
• Molecular Weight: 317.387
• Mol File: 1021685-17-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-(benzyloxy)-7-methoxy-3-methyl-9H-carbazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(benzyloxy)-7-methoxy-3-methyl-9H-carbazole(1021685-17-5)
• EPA Substance Registry System: 2-(benzyloxy)-7-methoxy-3-methyl-9H-carbazole(1021685-17-5)

Safety Data

• Hazardous Substances Data: 1021685-17-5(Hazardous Substances Data)

Upstream product

• 219492-12-3 3-(benzyloxy)-4-methylaniline 
• 1638631-78-3 3-benzyloxy-N-(3-methoxyphenyl)-4-methylaniline 
• 2398-37-0 3-methoxyphenyl bromide 
• 1114808-93-3 2-(benzyloxy)-4-bromo-1-methylbenzene 
• 36138-76-8 5-bromo-2-methylphenol 
• 100-39-0 benzyl bromide 
• 516521-49-6 1-(benzyloxy)-4-iodo-2-methylbenzene 
• 5344-78-5 4-bromo-3-nitroanizole 
• 60577-30-2 4-iodo-2-methyl-phenol 
• 1021685-18-6 4'-(benzyloxy)-4-methoxy-3'-methyl-2-nitrobiphenyl 

Downstream Products

• 119736-83-3 2-hydroxy-3-formyl-7-methoxycarbazole 
• 1638631-80-7 2-benzyloxy-7-methoxycarbazole-3-carbaldehyde 

Relevant articles and documents

Palladium(II)-catalyzed synthesis of the formylcarbazole alkaloids murrayaline A-C, 7-methoxymukonal, and 7-methoxy-o-methylmukonal

We describe the synthesis of the naturally occurring 2,7-dioxygenated formylcarbazole alkaloids 7-methoxymukonal, 7-methoxy-O-methylmukonal, and the murrayalines A-C. The carbazole framework was constructed by a Buchwald-Hartwig amination and a subsequent palladium(II)-catalyzed oxidative cyclization. We describe the synthesis of the naturally occurring 2,7-dioxygenated formylcarbazole alkaloids 7-methoxymukonal, 7-methoxy-O-methylmukonal, and the murrayalines A-C. The carbazole framework was constructed by a Buchwald-Hartwig amination and a subsequent palladium(II)-catalyzed oxidative cyclization. Copyright

FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION

The invention provides methods for the treatment of cancer in a subject comprising administering a dansyl-carbazole compound.

CANCER THERAPY

The present invention relates to methods of inducing expression of an epigenetically silenced gene, RASSFlA, in cells, particularly human cells, such as cancer cells. It also relates to methods of treating an individual, prophylactically or therapeutically, for cancer in which RASSFlA is epigenetically silenced.